Kusajili – Clinical trials directory

Result of your search per specialist: ROBIN Marie-Claude

Woman and Man
Between 18 years
and 99 years
Genentech Update Il y a 4 ans

GENENTECH ACF4375g : Essai de phase 1 évaluant la tolérance d’un traitement associant un anticorps anti-CD40 (SGN-40) à du bortézomib, chez des patients ayant un myélome multiple. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions] An open-label, phase Ib, dose-escalation study of the safety and pharmacology of the anti-CD40 monoclonal antibody SGN-40 administered in combination with bortezomib (Velcade®, PS-341) in patients wit...

Country France
organs Myélomes
Specialty Thérapies Ciblées

Essai clos aux inclusions

More information